Ignite Creation Date:
2025-12-26 @ 10:20 PM
Ignite Modification Date:
2026-01-16 @ 8:23 PM
Study NCT ID:
NCT02716012
Status:
UNKNOWN
Last Update Posted:
2025-03-10
First Post:
2016-03-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer
Sponsor:
Mina Alpha Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2016-03-11
First Submit QC Date:
None
Study First Post Date:
2016-03-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-05
Last Update Post Date:
2025-03-10
Last Update Post Date Type:
ACTUAL